Borderline Personality Disorder

Earn CME/CE in your profession:


Continuing Education Activity

Borderline personality disorder (BPD) is a mental health condition characterized by pervasive patterns of instability in mood, self-image, and interpersonal relationships, as well as marked impulsivity. Fear of abandonment and chronic feelings of emptiness further compound the complexity of this disorder. Individuals with BPD often experience intense and rapidly shifting emotions, have difficulty regulating their emotions, and engage in impulsive behavior, including recurrent self-harm and suicidality. BPD impacts an individual's interpersonal and occupational functioning, and people with BPD are high utilizers of health care and are challenging to treat. Some develop transient psychotic symptoms.

This course discussion focuses on 3 significant areas: the diagnosis of BPD, the pharmacologic and psychotherapeutic treatment of BPD, and the importance of an interdisciplinary team in managing patients with BPD. People with BPD may have comorbidities, such as mood disorders, anxiety disorders, eating disorders, and substance use disorders, posing additional diagnostic and therapeutic challenges. This activity empowers healthcare professionals by equipping them with the necessary knowledge and tools to provide optimal patient care for those individuals with BPD.

Objectives:

  • Apply the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision (DSM-5-TR) diagnostic criteria for borderline personality disorder.

  • Evaluate temperament and its clinical and diagnostic relevance to borderline personality disorder.

  • Assess the clinical presentation of borderline personality disorder and its common mental status examination findings.

  • Collaborate with an interdisciplinary team to improve care coordination in treating patients with borderline personality disorder.

Introduction

Borderline personality disorder (BPD) is a mental health condition characterized by pervasive patterns of instability in mood, self-image, and interpersonal relationships. People with BPD commonly have distorted perceptions of themselves and others, leading to difficulties in maintaining stable and healthy relationships. Individuals with BPD experience intense and rapidly shifting emotions, have difficulty regulating their emotions, and engage in impulsive behaviors. Fear of abandonment can drive maladaptive behaviors, including impulsivity, self-harming behaviors, and suicidality. Individuals with BPD can suffer from chronic feelings of emptiness. Mood disorders, anxiety disorders, eating disorders, posttraumatic stress disorder, other personality disorders, and substance use disorders can complicate BPD.[1]

The concept of BPD has evolved, and its history reflects changes in psychiatric understanding and diagnostic classifications. Hippocrates recorded early descriptions of intense, divergent moods.[2] What would later be recognized as BPD can be traced back to observations in the 1930s and 1940s. Psychiatrists such as Adolph Stern and Frieda Fromm-Reichmann made observations of patients who didn't neatly fit into existing diagnostic categories. In the 1950s, borderline conditions were often considered within the spectrum of schizophrenia. Psychiatrist Kurt Schneider used the term "borderline" to describe patients who were on the border between neurosis and psychosis. The term "borderline" gained more recognition in the 1960s and 1970s as psychiatrists and psychologists began to see a distinct group of patients with specific symptom patterns that didn't neatly fit into existing diagnostic categories.[3] Otto Kernberg and other psychoanalysts played a significant role in defining and describing borderline traits during this time. 

The formal recognition of BPD as a distinct diagnosis came with the publication of the third edition of The Diagnostic and Statistical Manual of Mental Disorders (DSM) in 1980. This marked a significant shift from previous conceptualizations, providing specific criteria for diagnosis and contributing to increased research and understanding. Subsequent editions of the DSM, such as the DSM-IV in 1994 and DSM-5 in 2013, refined the diagnostic criteria for BPD. These revisions aimed to improve the reliability and validity of the diagnosis, addressing some of the controversies and criticisms associated with earlier editions.[4][3]

The current version of the DSM, the DSM-5-TR, divides personality disorders into Cluster A, Cluster B, and Cluster C. Each cluster encompasses a distinct set of personality disorders with commonalities regarding symptoms, behaviors, and underlying psychological patterns.[5]

Cluster A refers to personality disorders with odd or eccentric characteristics. These include paranoid personality disorder, schizoid personality disorder, and schizotypal personality disorder. Individuals within this cluster often exhibit social withdrawal, peculiar or paranoid beliefs, and difficulties forming close relationships.

Cluster B comprises personality disorders with dramatic, emotional, or erratic behaviors. This cluster includes antisocial personality disorder, BPD, histrionic personality disorder, and narcissistic personality disorder. Individuals within this cluster often display impulsive actions, emotional instability, and challenges in maintaining stable relationships.

Cluster C consists of personality disorders with anxious and fearful characteristics. These include avoidant personality disorder, dependent personality disorder, and obsessive-compulsive personality disorder. Individuals within this cluster tend to experience significant anxiety, fear of abandonment, and an excessive need for control or perfectionism.

Despite the historical division of personality disorders into clusters, there are limitations when approaching personality disorders in this manner, and it is not consistently validated in the literature.[6]

Etiology

The current hypothesis is that BPD is caused by an interaction between genetic factors and adverse childhood experiences affecting brain development via neuropeptides and hormones.[7] The relative importance of these factors is unclear.[8]

Genetic studies propose a hereditary component of personality disorders, including BPD. The estimated heritability of BPD is approximately 40%.[8] In a Swedish population, the familial association of BPD was highest for monozygotic twins, then dizygotic twins, then full siblings, then half-siblings.[9] A caveat is that twin studies may overestimate the genetic effect on personality disorders, as twins are generally raised in a shared family environment.[10] Meta-analyses have not supported the proposed association of BPD with the serotonin transporter gene, the tryptophan hydroxylase 1 gene, or the serotonin 1B receptor gene, and there are no identified single-nucleotide variants associated with BPD.[8][11] 

Multiple factors within social and family domains contribute to increased risk for BPD, although none are disorder-specific. Indices of broader social risk include low socioeconomic status, family adversity, maternal psychopathology, parental substance use, low warmth/harsh punishment, child abuse, neglect, and low cognitive function. Studies also show links between temperament factors and later BPD.[12][13]

BPD must be distinguished from personality traits arising from other medical conditions. Conditions associated with personality changes include head trauma, cerebrovascular accident, CNS neoplasms, epilepsy, neurosyphilis, multiple sclerosis, endocrine disorders, heavy metal poisoning, and HIV-associated neurocognitive disorders.[14] 

Psychoanalytic approaches to BPD focus on unconscious processes, early childhood experiences, and the influence of internal conflicts.[15] Psychoanalyst Wilhelm Reich introduced the concept of "character armor," referring to defense mechanisms individuals develop to alleviate cognitive conflict arising from internal impulses and interpersonal anxiety.[16] Defense mechanisms associated with BPD are projection, splitting, and acting out, which are related to insecure attachment.[17][18] The term "splitting" refers to the defense mechanism in which the patient cannot form a realistic view of another person. At any given time, the other person is viewed as entirely good or entirely bad. This inability to view others as having both positive and negative attributes impairs personal relationships. Otto Kernberg theorized that lack of integration in the early maternal relationship led to BPD.[19] Kernberg hypothesized that the infant experiences the maternal figure in a dichotomous framework: the loving and nurturing mother who provides for the child and the punishing, hateful mother who deprives the child. This contradiction causes intense anxiety and, if not integrated into a more moderate unitary concept, leads to splitting. Kernberg also points out that BPD is complex and warns of reductionist shortcuts in searching for etiology.[19]

Personality is a unique pattern of behaviors that an individual adopts in response to constantly changing internal and external stimuli. It is a complex summation of biological, psychological, social, and developmental factors. Each personality is unique, even among those people grouped and labeled with a personality disorder. This uniqueness is broadly described as temperament, a heritable and innate psychobiological characteristic. Cloninger describes the 4 dimensions of temperament as harm avoidance, novelty seeking, reward dependence, and persistence, which are independently heritable.[20] Harm avoidance involves a bias towards inhibiting behavior that would result in punishment or non-reward.[21] Individuals with BPD may have higher harm avoidance and fearful, anxiety-prone traits.[22][23] Novelty seeking is an inherent desire to initiate novel activities likely to produce a reward signal. Individuals with BPD tend to have a high amount of novelty-seeking behaviors.[22][23] Temperament is further shaped through life experiences such as trauma and socioeconomic conditions; these are adaptive etiological factors in personality development.[24][25] 

Epidemiology

Nationwide epidemiologic studies estimate the prevalence of BPD in the general population between 0.7% and 2.7%, with symptoms usually manifesting in early adulthood.[26][27][28] In primary care, the prevalence is 6%, and the rate is 11% to 12% in outpatient psychiatric clinics and 22% for psychiatric inpatients.[29] Although women have a slightly higher rate of BPD than men (3% versus 2.4%), in outpatient psychiatric settings, there are higher rates of BPD in women (78% versus 28%).[30][31][32]

Pathophysiology

Current neurobiological models of BPD link findings across neuroendocrinology, structural neuroimaging, and functional neuroimaging. Specific genes may be involved with disruptions in the hypothalamic-pituitary-adrenal axis consistent with stress-related changes and chronic elevation of cortisol, affecting emotional regulation and impulse control.[33] Neuroimaging studies have identified differences in the amygdala, hippocampus, and medial temporal lobes in patients with BPD, which may also be related to self-reported childhood trauma.

Top-down control abnormalities are seen in BPD, showing that cortical activity to moderate the amygdala (and other limbic areas) is impaired. Instead, behavior is driven from the bottom-up, meaning that amygdala activation is unmoderated by higher-level cortical functions.[34] Studies also suggest that patients with BPD may misattribute negative emotions (fear, anger, disgust) to neutral faces more than control patients despite having the perception of happy and upset faces equivalent to those groups.[35] On neuropsychological testing, patients with BPD have impaired cognitive flexibility and increased impulsivity. No correlation was found between BPD symptom severity and cognitive functions.[36][37]

History and Physical

The presentation of BPD is variable. Obtaining a thorough psychiatric history, medical history, social history, developmental history, and history of family dynamics is essential for diagnosis. The features of BPD may start emerging in adolescence, and impulsive and dangerous behaviors may increase through early adulthood. The presence of affective instability identifies most patients with BPD, who describe fluctuating moods throughout the day depending on circumstances and interactions with others. This mood instability is different than a depressive episode or manic episode, both of which have more consistent mood symptoms.[38] Individuals with BPD display wide emotional lability, including the potential to react strongly and become angry, violent, or suicidal.

Inquiring about the patient's relationships with family, friends, and romantic partners can help diagnose patients with suspected BPD. Splitting is common, viewing others as "all good" or "all bad" from moment to moment. Individuals with BPD can become dependent on others but also have dramatic shifts in their feelings when feeling abandoned or disregarded.[39] Men with BPD are more impaired, impulsive, and aggressive than women with BPD and may be at higher risk of dying by suicide.[40] People with BPD describe chronic feelings of "emptiness" related to hopelessness, loneliness, and isolation.[41] Maladaptive coping is inherent in the diagnosis of BPD. It can present as substance use, impulsive spending, high-risk sexual behavior, binge eating, reckless driving, self-harm, or self-sabotaging behaviors. Body modification by excessive piercings, tattoos, or scarification can represent identity diffusion and low self-concept clarity and may be connected to BPD.[42] 

Self-harming behavior can be either nonsuicidal self-harm or suicidal behavior (with the intent to die). Nonsuicidal self-harm can be expressed by deliberate cutting among women and hitting one's own body in men. Suicide methods include hanging oneself, shooting oneself, jumping off a tall structure, substance overdose, and refusing fluids and food. Nonsuicidal self-harm and suicidal behavior are interrelated, and self-harming behavior is a risk factor for future suicide. Any self-harming behavior should be carefully assessed for intent to die.[43][44] Suicidal behaviors tend to remit over time, but suicidality may continue when BPD symptoms are untreated or severe or if the patient is poorly functioning. Another risk factor for suicide is comorbid major depressive disorder.[45] 

The mental status examination is crucial in assessing individuals for BPD. The specific elements and findings of the examination can vary depending on each case of BPD. Assessment of patients should include the following:

  • Appearance: Individuals with BPD may have excessive tattoos, piercings, or scarification. The patient should be assessed for scars from cutting.[42]                                                                                                
  • Behavior: Splitting behavior may be present, and the clinician should be sensitive to this dynamic. Patients with BPD may be angry, antagonistic, or violent.                                                                                  
  • Affect: Patients with BPD may present with constricted, dysphoric, or angry affect.                                               
  • Thought content: Assess for thoughts of self-harm, suicidality, or thoughts of harming others. Transient psychosis may be present.                                                                                                                              
  • Thought process: Individuals with BPD are usually clear and coherent but may dissociate at times.                                     
  • Cognition: Individuals with BPD are usually cognitively intact and oriented to person, place, and date.                                      
  • Insight: Typically, individuals with BPD have a poor understanding of how their behaviors are related to their feelings, dysregulated emotions, and interpersonal difficulties.                                                                        
  • Judgment and impulse control: Poor judgment and poor impulse control are common in patients with BPD. 

Evaluation

Diagnosis of BPD is based on the longitudinal observation of a patient's behaviors to assess functioning over time. The symptoms of a personality disorder may overlap with symptoms observed during acute psychiatric conditions such as mood disorders. If possible, personality disorders should be diagnosed when other psychiatric conditions are quiescent.[46] BPD can also significantly contribute to the exacerbation of another psychiatric illness and lead to hospitalization.[47] 

Clinicians often develop a psychological reaction to patients with BPD, which is known as "countertransference." This occurs due to the nature of the encounters, as patients may be difficult, aggressive, self-harming, or suicidal.[48] Clinicians must recognize signs of countertransference, which may negatively affect patient care.[49] When clinicians feel frustrated with patients who may be suffering from a personality disorder, it is helpful to use those feelings as an evaluation tool to guide diagnosis and treatment.[50][51]

Evidence-based assessment of BPD can include a self-report inventory, such as the 10-item, true-false McLean Screening Instrument for BPD. A score of 7 or more yields both good sensitivity and specificity for diagnosing BPD. The Zanarini rating scale is another common tool used to screen for BPD.[52]

Psychological testing can help diagnose personality disorders but is not generally needed for a diagnosis of BPD when a sufficient history is available. The Minnesota Multiphasic Personality Inventory-2 and the Rorschach Perceptual Thinking Index may be used to verify the presence of a personality disorder.[53][54][55] Individuals must meet the diagnostic criteria specified in the DSM-5-T to formally diagnose BPDR. The diagnosis requires a thorough evaluation that considers multiple sources of information, including personal history, collateral information, and a mental status examination. A comprehensive assessment allows clinicians to assess the individual's symptoms, functioning, and overall presentation to see if diagnostic criteria are met.

DSM-5-TR Categorical Criteria for BPD

A pervasive pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts, as indicated by 5 or more of the following:

  1. Frantic efforts to avoid real or imagined abandonment                                                                                         
  2. A pattern of unstable and intense interpersonal relationships characterized by alternating between extremes of idealization and devaluation                                                                                                         
  3. Identity disturbance: markedly and persistently unstable self-image or sense of self                                                 
  4. Impulsivity in at least 2 areas that are potentially self-damaging, for example, spending, substance abuse, reckless driving, sex, or binge eating                                                                                                                 
  5. Recurrent suicidal behavior, gestures, or threats, or self-mutilating behavior                                                                                                         
  6. Affective instability due to a marked reactivity of mood, for example, intense episodic dysphoria, anxiety, or irritability, usually lasting a few hours and rarely more than a few days                                                                                                                                        
  7. Chronic feelings of emptiness                                                                                                                                
  8. Inappropriate, intense anger or difficulty controlling anger, for example, frequent displays of temper, constant anger, or recurrent physical fights                                                                                                                                                          
  9. Transient, stress-related paranoid ideation or severe dissociative symptoms                                      

DSM-5-TR Alternative Dimensional Model for Diagnosing BPD

To preserve continuity with the categorical diagnostic model, the DSM-5-TR includes a hybrid dimensional-categorical model that defines personality disorders in terms of personality functioning and pathological traits. This approach acknowledges that individuals do not usually present with symptoms of just 1 personality disorder.

The proposed diagnostic criteria for BPD include 2 sets of characteristic difficulties. First, there is moderate or greater impairment in personality functioning manifested by problems in 2 or more areas: identity, self-direction, empathy, or intimacy. Second, 4 or more of the following personality traits must be present: emotional lability, anxiousness, separation insecurity, depressivity, impulsivity, risk-taking, or hostility. At least 1 must be impulsivity, risk-taking, or hostility.  

Treatment / Management

The first-line treatment for BPD is psychotherapy.[56][57] BPD-tailored therapies are effective for patients with BPD compared to treatment as usual. In clinical trials, psychotherapy improved psychosocial functioning, reduced the severity of BPD symptoms, and may reduce self-harm and depression. The efficacy of psychotherapy for adolescents is not known due to the lack of high-quality studies.[7]

Mentalization-based treatment (MBT) is a complex attachment-based psychological therapy program that helps patients with BPD regulate emotions by increasing their mentalizing capacity and reflective functioning. Patients can then understand and recognize their feelings and the feelings they evoke in others. MBT combines individual therapy and group therapy.[7]

Dialectical behavioral therapy (DBT) is a highly structured psychological therapy that combines mindfulness practices with concrete interpersonal and emotion regulation skills based on cognitive behavioral therapy. DBT aims to change behavior and enable the patient to tolerate distressing feelings by skill-building in emotion regulation, mindfulness, and interpersonal behavior. DBT combines individual therapy, group therapy, and weekly team consultations for the therapists.[7]

Transference-focused psychotherapy (TFP) uses the patient-therapist relationship to develop the patient's awareness of problematic interpersonal dynamics. The therapist uses clarification, confrontation, and transference interpretation within the relationship between the patient and the therapist.[7]

The goal of schema therapy (ST) is the development of a healthy adult. ST addresses 4 dysfunctional life schemas characteristic of BPD: the abandoned/abused child, the angry/impulsive child, the detached protector, and the punitive parent. Cognitive-behavioral, psychodynamic, attachment, and emotion-focused approaches characterize ST.[7]

There is no evidence that pharmacotherapy is efficacious for BPD core symptoms, yet contrary to guidelines, up to 96% of patients with BPD receive at least 1 psychotropic medication, and polypharmacy is common.[58] No medications are FDA-approved for the treatment of BPD.[56] Medications such as serotonin reuptake inhibitors (SRIs), mood stabilizers, and antipsychotic medications show limited effectiveness in trials aimed at the control of transient symptoms of anxiety, sleep disturbance, depression, or agitation.[59] Pharmacotherapy is only recommended for the treatment of comorbid disorders such as severe depression or anxiety, transient psychotic symptoms, severe agitation, or aggressive behavior.[7]

Polypharmacy can be associated with iatrogenic harm and contribute to functional impairment. Consider reducing patients' high-risk polypharmacy regimens when determining the risks and benefits of a treatment regimen.[60]

Self-injurious behavior, boundary issues, suicidality, and substance use present challenges in the treatment of patients with BPD.

Patients with BPD do not typically require hospitalization; however, inpatient care may be necessary in certain situations as follows:

  • Overt suicidal ideation with imminent risk of high lethality behavior                                                                                 
  • Intense negative thoughts, agitation, or transient psychosis                                                                                              
  • Rapid escalation in the severity of self-harm                                                                                                        
  • Exacerbation of comorbid psychiatric disorders or substance use disorders

Differential Diagnosis

BPD often co-occurs with depressive or bipolar disorders, which should be diagnosed if the criteria for those disorders are met. Exacerbations of BPD can mimic mood disorders, so the diagnosis of BPD should only be made based on documented long-standing patterns of behavior. 

Both separation anxiety and BPD are characterized by fear of abandonment, but problems with impulsivity, identity, and interpersonal functioning are needed to diagnose BPD.

Personality disorders have overlapping features and can be confused with BPD. It is essential to distinguish BPD by its characteristic features. If an individual meets the criteria for more than 1 personality disorder, the other personality disorders can be diagnosed.

Dissociative identity disorder is characterized by 2 or more personality states that are each distinct and with an enduring pattern of behavior. In BPD, there are problems with identity and self-image, but these are transient, unstable, and fluctuate. 

Persistent substance use can lead to symptoms that mimic BPD.

BPD must be distinguished from personality traits arising from another medical condition. Conditions associated with personality changes include head trauma, cerebrovascular accident, CNS neoplasms, epilepsy, neurosyphilis, multiple sclerosis, endocrine disorders, heavy metal poisoning, and HIV-associated neurocognitive disorders.[14] 

Pertinent Studies and Ongoing Trials

There are significant limitations to existing models for describing personality disorders, including BPD. The "cluster" system is commonly used due to its implementation in the DSM. Similar patterns of behavior are classified into syndromes known as personality disorders; however, the uniqueness of each person remains a problem for the diagnosis and research into each specific personality disorder as patterns overlap and diverge.[6] 

Experts in personality disorders suggest switching to a dimensional model of personality. Dimensional models generally describe temperament, utilization of defense mechanisms, and pathological personality traits to diagnose personality disorders.[61] 

The DSM-5-TR Alternative Dimensional Model for Diagnosing BPD preserves continuity with the categorical diagnostic model with a hybrid dimensional-categorical model that defines personality disorders in terms of personality functioning and pathological traits. This approach also acknowledges that individuals do not usually present with symptoms of just 1 personality disorder.

The paradigm will likely shift further towards a dimensional model as research informs evolving clinical guidelines about diagnosis and treatment. In addition, high-quality head-to-head trials of the major forms of psychotherapy and studies of the nature of mechanisms of change are needed.

Prognosis

Patients with BPD have a fair prognosis, and studies demonstrate that BPD psychopathology improves more than generally expected but that psychosocial functioning often remains impaired. Systematic meta-analysis with 5- to 15-year follow-up periods showed mean remission rates of 60%.[62]

Despite high rates of remission and low rates of relapse, patients with BPD have severe and persistent impairment in functional and social recovery. This is consistent with the theory that with stable supports and avoidance of interpersonal stressors, patients with BPD remit clinically. Patients with persistent BPD were more likely to have had inpatient treatment and had more comorbid borderline psychopathology.[63][64][65]

Complications

Patients with BPD have a higher rate of suicide (5.9%) than patients with other personality disorders (1.4%). In 1 study, more than 75% of patients with BPD had suicide attempts.[7][66] Other complications of BPD include comorbid medical conditions such as obesity, diabetes, gastrointestinal disease, cardiovascular disease, hypertension, chronic pain, and sexually transmitted diseases. There is a strong association between BPD and all other personality disorders, mood disorders, eating disorders, posttraumatic stress disorder, and substance use disorders. People with BPD have a poorer life expectancy than others and struggle to negotiate the health care system.[7][67][68]

Deterrence and Patient Education

The treatment of BPD is contingent upon developing and maintaining a therapeutic alliance in the face of the impaired interpersonal relationships that complicate engagement between clinician and patient. Patients with BPD may have unstable emotional states, be highly demanding, act out, and push the limits of the relationship. Needy patients can strain treatment relationship boundaries. Patients can be engaged by seeking relationships and may respond to warmth and support. Therapists can offer reassurance that the environment is safe and supportive, and encourage patients to describe their symptoms and communicate psychosocial stressors. Clinicians should aim to understand and address the specific concerns and challenges the patient with BPD faces, particularly when the patient is not in acute distress or crisis. Patients can be encouraged to utilize support networks through their remaining social relationships and group involvement.[69] 

Pearls and Other Issues

Key insights and strategies to navigate the complexities of BPD, optimizing patient care and treatment outcomes include the following:

  • Patients with BPD can be challenging to treat due to splitting dynamics, and it is important to maintain boundaries in the provider-patient relationship.                                                                                                  
  • Suicidality and self-harm behaviors should be regularly assessed and addressed, coordinating with emergency services as needed. Safety plans should be implemented.                                                                                               
  • Psychotherapy is the treatment of choice with mentalization-based treatment (MBT), dialectical behavioral therapy (DBT), transference-focused psychotherapy (TFP), and schema therapy (ST) having evidence of efficacy.
  • There are no psychopharmacologic treatments shown to be helpful in the routine treatment of BPD, and polypharmacy should be avoided.                                                                                                                                                      
  • Comorbid conditions such as depression, anxiety, substance abuse, and eating disorders, which can complicate BPD management, should be recognized and addressed.

Enhancing Healthcare Team Outcomes

Patients with BPD are high utilizers of health care. Early identification and management of patients with BPD is imperative in reducing morbidity and mortality. Caring for patients with BPD requires a collaborative approach among healthcare professionals to ensure patient-centered care and improve overall outcomes. Psychiatrists, advanced care practitioners, emergency medicine physicians, primary care physicians, nurses, pharmacists, and other health professionals involved in caring for patients with BPD should possess essential clinical skills and knowledge to accurately diagnose and manage BPD. This includes expertise in recognizing the varied clinical presentations and understanding the nuances of diagnosis. Team approaches that include social work, vocational rehabilitation, and recreational therapy improve outcomes in BPD.

A strategic approach should use evidence-based strategies to optimize treatment plans and minimize adverse effects. Ethical considerations must guide decision-making, ensuring informed consent and respecting patient autonomy in treatment choices. Each healthcare professional must be aware of their responsibilities and contribute their unique expertise to the patient's care plan, fostering a multidisciplinary approach and avoiding splitting. Effective interprofessional communication is paramount, allowing seamless information exchange and collaborative decision-making among the team members. Care coordination plays a pivotal role in ensuring that the patient's journey from diagnosis to treatment and follow-up is well-managed, minimizing errors and enhancing patient safety. By embracing these principles of skill, strategy, ethics, responsibilities, interprofessional communication, and care coordination, healthcare professionals can deliver patient-centered care, ultimately improving patient outcomes and enhancing team performance in the management of patients affected by BPD.


Details

Author

Carl Fleisher

Updated:

4/20/2024 3:31:39 PM

Looking for an easier read?

Click here for a simplified version

References


[1]

Biskin RS. The Lifetime Course of Borderline Personality Disorder. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 2015 Jul:60(7):303-8     [PubMed PMID: 26175388]


[2]

Sedivec V. [Mental disorders in the writings of Hippocrates]. Ceskoslovenska psychiatrie. 1989 Aug:85(4):270-3     [PubMed PMID: 2680117]


[3]

Bateman A, Fonagy P. Mentalization based treatment for borderline personality disorder. World psychiatry : official journal of the World Psychiatric Association (WPA). 2010 Feb:9(1):11-5     [PubMed PMID: 20148147]


[4]

Hörz-Sagstetter S, Ohse L, Kampe L. Three Dimensional Approaches to Personality Disorders: a Review on Personality Functioning, Personality Structure, and Personality Organization. Current psychiatry reports. 2021 Jun 28:23(7):45. doi: 10.1007/s11920-021-01250-y. Epub 2021 Jun 28     [PubMed PMID: 34181116]


[5]

Hopwood CJ, Thomas KM, Markon KE, Wright AG, Krueger RF. DSM-5 personality traits and DSM-IV personality disorders. Journal of abnormal psychology. 2012 May:121(2):424-32. doi: 10.1037/a0026656. Epub 2012 Jan 16     [PubMed PMID: 22250660]


[6]

Tackett JL, Silberschmidt AL, Krueger RF, Sponheim SR. A dimensional model of personality disorder: incorporating DSM Cluster A characteristics. Journal of abnormal psychology. 2008 May:117(2):454-9. doi: 10.1037/0021-843X.117.2.454. Epub     [PubMed PMID: 18489222]


[7]

Leichsenring F, Fonagy P, Heim N, Kernberg OF, Leweke F, Luyten P, Salzer S, Spitzer C, Steinert C. Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies. World psychiatry : official journal of the World Psychiatric Association (WPA). 2024 Feb:23(1):4-25. doi: 10.1002/wps.21156. Epub     [PubMed PMID: 38214629]


[8]

Amad A, Ramoz N, Thomas P, Jardri R, Gorwood P. Genetics of borderline personality disorder: systematic review and proposal of an integrative model. Neuroscience and biobehavioral reviews. 2014 Mar:40():6-19. doi: 10.1016/j.neubiorev.2014.01.003. Epub 2014 Jan 20     [PubMed PMID: 24456942]

Level 1 (high-level) evidence

[9]

Skoglund C, Tiger A, Rück C, Petrovic P, Asherson P, Hellner C, Mataix-Cols D, Kuja-Halkola R. Familial risk and heritability of diagnosed borderline personality disorder: a register study of the Swedish population. Molecular psychiatry. 2021 Mar:26(3):999-1008. doi: 10.1038/s41380-019-0442-0. Epub 2019 Jun 3     [PubMed PMID: 31160693]


[10]

Torgersen S. Genetics of patients with borderline personality disorder. The Psychiatric clinics of North America. 2000 Mar:23(1):1-9     [PubMed PMID: 10729927]


[11]

Sanchez-Roige S, Gray JC, MacKillop J, Chen CH, Palmer AA. The genetics of human personality. Genes, brain, and behavior. 2018 Mar:17(3):e12439. doi: 10.1111/gbb.12439. Epub 2017 Dec 29     [PubMed PMID: 29152902]


[12]

Stepp SD, Lazarus SA, Byrd AL. A systematic review of risk factors prospectively associated with borderline personality disorder: Taking stock and moving forward. Personality disorders. 2016 Oct:7(4):316-323     [PubMed PMID: 27709988]

Level 1 (high-level) evidence

[13]

Bozzatello P, Rocca P, Baldassarri L, Bosia M, Bellino S. The Role of Trauma in Early Onset Borderline Personality Disorder: A Biopsychosocial Perspective. Frontiers in psychiatry. 2021:12():721361. doi: 10.3389/fpsyt.2021.721361. Epub 2021 Sep 23     [PubMed PMID: 34630181]

Level 3 (low-level) evidence

[14]

Leppla I, Fishman D, Kalra I, Oldham MA. Clinical Approach to Personality Change Due to Another Medical Condition. Journal of the Academy of Consultation-Liaison Psychiatry. 2021 Jan-Feb:62(1):14-21. doi: 10.1016/j.psym.2020.08.003. Epub 2020 Sep 12     [PubMed PMID: 33190792]


[15]

Scarpa A, Raine A. Psychophysiology of anger and violent behavior. The Psychiatric clinics of North America. 1997 Jun:20(2):375-94     [PubMed PMID: 9196920]


[16]

Nielsen DA, Goldman D, Virkkunen M, Tokola R, Rawlings R, Linnoila M. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Archives of general psychiatry. 1994 Jan:51(1):34-8     [PubMed PMID: 7506517]


[17]

Tanzilli A, Di Giuseppe M, Giovanardi G, Boldrini T, Caviglia G, Conversano C, Lingiardi V. Mentalization, attachment, and defense mechanisms: a Psychodynamic Diagnostic Manual-2-oriented empirical investigation. Research in psychotherapy (Milano). 2021 Mar 31:24(1):531. doi: 10.4081/ripppo.2021.531. Epub 2021 Mar 29     [PubMed PMID: 33937117]


[18]

Zanarini MC, Weingeroff JL, Frankenburg FR. Defense mechanisms associated with borderline personality disorder. Journal of personality disorders. 2009 Apr:23(2):113-21. doi: 10.1521/pedi.2009.23.2.113. Epub     [PubMed PMID: 19379090]


[19]

Kernberg OF, Michels R. Borderline personality disorder. The American journal of psychiatry. 2009 May:166(5):505-8. doi: 10.1176/appi.ajp.2009.09020263. Epub     [PubMed PMID: 19411373]


[20]

Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Archives of general psychiatry. 1993 Dec:50(12):975-90     [PubMed PMID: 8250684]


[21]

Wan L, Zha R, Ren J, Li Y, Zhao Q, Zuo H, Zhang X. Brain morphology, harm avoidance, and the severity of excessive internet use. Human brain mapping. 2022 Jul:43(10):3176-3183. doi: 10.1002/hbm.25842. Epub 2022 Mar 25     [PubMed PMID: 35332975]


[22]

Kouros I, Holmberg H, Ekselius L, Ramklint M. Temperament, but not childhood trauma, distinguishes borderline personality disorder from bipolar disorder and ADHD. Nordic journal of psychiatry. 2024 Jan:78(1):79-86. doi: 10.1080/08039488.2023.2267041. Epub 2024 Jan 8     [PubMed PMID: 37870069]


[23]

Réale D, Reader SM, Sol D, McDougall PT, Dingemanse NJ. Integrating animal temperament within ecology and evolution. Biological reviews of the Cambridge Philosophical Society. 2007 May:82(2):291-318     [PubMed PMID: 17437562]

Level 3 (low-level) evidence

[24]

Svrakic DM, Cloninger RC. Epigenetic perspective on behavior development, personality, and personality disorders. Psychiatria Danubina. 2010 Jun:22(2):153-66     [PubMed PMID: 20562740]

Level 3 (low-level) evidence

[25]

Gescher DM, Kahl KG, Hillemacher T, Frieling H, Kuhn J, Frodl T. Epigenetics in Personality Disorders: Today's Insights. Frontiers in psychiatry. 2018:9():579. doi: 10.3389/fpsyt.2018.00579. Epub 2018 Nov 19     [PubMed PMID: 30510522]


[26]

Clarkin JF, Widiger TA, Frances A, Hurt SW, Gilmore M. Prototypic typology and the borderline personality disorder. Journal of abnormal psychology. 1983 Aug:92(3):263-75     [PubMed PMID: 6619404]


[27]

Nasiri H, Abedi A, Ebrahimi A, Ameli SS, Samouei R. Personality profile of women affected with borderline personality disorder. Materia socio-medica. 2013:25(1):60-3. doi: 10.5455/msm.2013.25.60-63. Epub     [PubMed PMID: 23687463]


[28]

Eaton NR, Greene AL. Personality disorders: community prevalence and socio-demographic correlates. Current opinion in psychology. 2018 Jun:21():28-32. doi: 10.1016/j.copsyc.2017.09.001. Epub 2017 Sep 14     [PubMed PMID: 28961462]

Level 3 (low-level) evidence

[29]

Ellison WD, Rosenstein LK, Morgan TA, Zimmerman M. Community and Clinical Epidemiology of Borderline Personality Disorder. The Psychiatric clinics of North America. 2018 Dec:41(4):561-573. doi: 10.1016/j.psc.2018.07.008. Epub 2018 Oct 16     [PubMed PMID: 30447724]


[30]

Zimmerman M, Becker L. The hidden borderline patient: patients with borderline personality disorder who do not engage in recurrent suicidal or self-injurious behavior. Psychological medicine. 2023 Aug:53(11):5177-5184. doi: 10.1017/S0033291722002197. Epub 2022 Jul 29     [PubMed PMID: 35903008]


[31]

Lenzenweger MF, Lane MC, Loranger AW, Kessler RC. DSM-IV personality disorders in the National Comorbidity Survey Replication. Biological psychiatry. 2007 Sep 15:62(6):553-64     [PubMed PMID: 17217923]

Level 3 (low-level) evidence

[32]

Grant BF, Chou SP, Goldstein RB, Huang B, Stinson FS, Saha TD, Smith SM, Dawson DA, Pulay AJ, Pickering RP, Ruan WJ. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of clinical psychiatry. 2008 Apr:69(4):533-45     [PubMed PMID: 18426259]

Level 3 (low-level) evidence

[33]

Ruocco AC, Carcone D. A Neurobiological Model of Borderline Personality Disorder: Systematic and Integrative Review. Harvard review of psychiatry. 2016 Sep-Oct:24(5):311-29. doi: 10.1097/HRP.0000000000000123. Epub     [PubMed PMID: 27603741]

Level 1 (high-level) evidence

[34]

Kulacaoglu F, Kose S. Borderline Personality Disorder (BPD): In the Midst of Vulnerability, Chaos, and Awe. Brain sciences. 2018 Nov 18:8(11):. doi: 10.3390/brainsci8110201. Epub 2018 Nov 18     [PubMed PMID: 30453675]


[35]

Law MK, Fleeson W, Arnold EM, Furr RM. Using Negative Emotions to Trace the Experience of Borderline Personality Pathology: Interconnected Relationships Revealed in an Experience Sampling Study. Journal of personality disorders. 2016 Feb:30(1):52-70. doi: 10.1521/pedi_2015_29_180. Epub 2015 Feb 24     [PubMed PMID: 25710731]


[36]

Aslan IH, Grant JE, Chamberlain SR. Cognition in adults with borderline personality disorder. CNS spectrums. 2023 Dec:28(6):674-679. doi: 10.1017/S1092852923001177. Epub 2023 Mar 16     [PubMed PMID: 36924168]


[37]

Baird AA, Veague HB, Rabbitt CE. Developmental precipitants of borderline personality disorder. Development and psychopathology. 2005 Fall:17(4):1031-49     [PubMed PMID: 16613429]


[38]

Zimmerman M, Multach MD, Dalrymple K, Chelminski I. Clinically useful screen for borderline personality disorder in psychiatric out-patients. The British journal of psychiatry : the journal of mental science. 2017 Feb:210(2):165-166. doi: 10.1192/bjp.bp.116.182121. Epub 2016 Dec 1     [PubMed PMID: 27908898]


[39]

Ruocco AC. The neuropsychology of borderline personality disorder: a meta-analysis and review. Psychiatry research. 2005 Dec 15:137(3):191-202     [PubMed PMID: 16297985]

Level 1 (high-level) evidence

[40]

Sher L, Rutter SB, New AS, Siever LJ, Hazlett EA. Gender differences and similarities in aggression, suicidal behaviour, and psychiatric comorbidity in borderline personality disorder. Acta psychiatrica Scandinavica. 2019 Feb:139(2):145-153. doi: 10.1111/acps.12981. Epub 2018 Nov 12     [PubMed PMID: 30353921]


[41]

Klonsky ED. What is emptiness? Clarifying the 7th criterion for borderline personality disorder. Journal of personality disorders. 2008 Aug:22(4):418-26. doi: 10.1521/pedi.2008.22.4.418. Epub     [PubMed PMID: 18684053]


[42]

Vizgaitis AL, Lenzenweger MF. Pierced identities: Body modification, borderline personality features, identity, and self-concept disturbances. Personality disorders. 2019 Mar:10(2):154-162. doi: 10.1037/per0000309. Epub 2018 Aug 16     [PubMed PMID: 30113185]


[43]

Reichl C, Kaess M. Self-harm in the context of borderline personality disorder. Current opinion in psychology. 2021 Feb:37():139-144. doi: 10.1016/j.copsyc.2020.12.007. Epub 2021 Jan 6     [PubMed PMID: 33548678]

Level 3 (low-level) evidence

[44]

Paris J. Suicidality in Borderline Personality Disorder. Medicina (Kaunas, Lithuania). 2019 May 28:55(6):. doi: 10.3390/medicina55060223. Epub 2019 May 28     [PubMed PMID: 31142033]


[45]

Soloff PH, Chiappetta L. 10-Year Outcome of Suicidal Behavior in Borderline Personality Disorder. Journal of personality disorders. 2019 Feb:33(1):82-100. doi: 10.1521/pedi_2018_32_332. Epub 2018 Feb 22     [PubMed PMID: 29469667]


[46]

Clark LA. Assessment and diagnosis of personality disorder: perennial issues and an emerging reconceptualization. Annual review of psychology. 2007:58():227-57     [PubMed PMID: 16903806]


[47]

Campbell K, Clarke KA, Massey D, Lakeman R. Borderline Personality Disorder: To diagnose or not to diagnose? That is the question. International journal of mental health nursing. 2020 Oct:29(5):972-981. doi: 10.1111/inm.12737. Epub 2020 May 19     [PubMed PMID: 32426937]


[48]

Sansone RA, Sansone LA. Responses of mental health clinicians to patients with borderline personality disorder. Innovations in clinical neuroscience. 2013 May:10(5-6):39-43     [PubMed PMID: 23882440]


[49]

Parth K, Datz F, Seidman C, Löffler-Stastka H. Transference and countertransference: A review. Bulletin of the Menninger Clinic. 2017 Spring:81(2):167-211. doi: 10.1521/bumc.2017.81.2.167. Epub     [PubMed PMID: 28609147]


[50]

Knaak S, Mantler E, Szeto A. Mental illness-related stigma in healthcare: Barriers to access and care and evidence-based solutions. Healthcare management forum. 2017 Mar:30(2):111-116. doi: 10.1177/0840470416679413. Epub 2017 Feb 16     [PubMed PMID: 28929889]


[51]

Bodner E, Cohen-Fridel S, Mashiah M, Segal M, Grinshpoon A, Fischel T, Iancu I. The attitudes of psychiatric hospital staff toward hospitalization and treatment of patients with borderline personality disorder. BMC psychiatry. 2015 Jan 22:15():2. doi: 10.1186/s12888-014-0380-y. Epub 2015 Jan 22     [PubMed PMID: 25609479]


[52]

Zanarini MC, Weingeroff JL, Frankenburg FR, Fitzmaurice GM. Development of the self-report version of the Zanarini Rating Scale for Borderline Personality Disorder. Personality and mental health. 2015 Nov:9(4):243-9. doi: 10.1002/pmh.1302. Epub 2015 Jul 14     [PubMed PMID: 26174588]


[53]

Widiger TA, Hines A, Crego C. Evidence-Based Assessment of Personality Disorder. Assessment. 2024 Jan:31(1):191-198. doi: 10.1177/10731911231176461. Epub 2023 May 25     [PubMed PMID: 37231676]


[54]

Dao TK, Prevatt F, Horne HL. Differentiating psychotic patients from nonpsychotic patients with the MMPI-2 and Rorschach. Journal of personality assessment. 2008 Jan:90(1):93-101. doi: 10.1080/00223890701693819. Epub     [PubMed PMID: 18444100]


[55]

Sellbom M, Ben-Porath YS, Lilienfeld SO, Patrick CJ, Graham JR. Assessing psychopathic personality traits with the MMPI-2. Journal of personality assessment. 2005 Dec:85(3):334-43     [PubMed PMID: 16318573]


[56]

Choi-Kain LW, Finch EF, Masland SR, Jenkins JA, Unruh BT. What Works in the Treatment of Borderline Personality Disorder. Current behavioral neuroscience reports. 2017:4(1):21-30. doi: 10.1007/s40473-017-0103-z. Epub 2017 Feb 3     [PubMed PMID: 28331780]


[57]

Storebø OJ, Stoffers-Winterling JM, Völlm BA, Kongerslev MT, Mattivi JT, Jørgensen MS, Faltinsen E, Todorovac A, Sales CP, Callesen HE, Lieb K, Simonsen E. Psychological therapies for people with borderline personality disorder. The Cochrane database of systematic reviews. 2020 May 4:5(5):CD012955. doi: 10.1002/14651858.CD012955.pub2. Epub 2020 May 4     [PubMed PMID: 32368793]

Level 1 (high-level) evidence

[58]

Bridler R, Häberle A, Müller ST, Cattapan K, Grohmann R, Toto S, Kasper S, Greil W. Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2015 Jun:25(6):763-72. doi: 10.1016/j.euroneuro.2015.03.017. Epub 2015 Apr 11     [PubMed PMID: 25907249]


[59]

Parker JD, Naeem A. Pharmacologic Treatment of Borderline Personality Disorder. American family physician. 2019 Mar 1:99(5):Online     [PubMed PMID: 30811158]


[60]

Madan A, Oldham JM, Gonzalez S, Fowler JC. Reducing Adverse Polypharmacy in Patients With Borderline Personality Disorder: An Empirical Case Study. The primary care companion for CNS disorders. 2015:17(4):. doi: 10.4088/PCC.14m01760. Epub 2015 Jul 30     [PubMed PMID: 26693036]

Level 3 (low-level) evidence

[61]

Trull TJ, Widiger TA. Dimensional models of personality: the five-factor model and the DSM-5. Dialogues in clinical neuroscience. 2013 Jun:15(2):135-46     [PubMed PMID: 24174888]


[62]

Winsper C. Borderline personality disorder: course and outcomes across the lifespan. Current opinion in psychology. 2021 Feb:37():94-97. doi: 10.1016/j.copsyc.2020.09.010. Epub 2020 Sep 22     [PubMed PMID: 33091693]

Level 3 (low-level) evidence

[63]

Gunderson JG, Stout RL, McGlashan TH, Shea MT, Morey LC, Grilo CM, Zanarini MC, Yen S, Markowitz JC, Sanislow C, Ansell E, Pinto A, Skodol AE. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Archives of general psychiatry. 2011 Aug:68(8):827-37. doi: 10.1001/archgenpsychiatry.2011.37. Epub 2011 Apr 4     [PubMed PMID: 21464343]


[64]

Links PS, Heslegrave R, van Reekum R. Prospective follow-up study of borderline personality disorder: prognosis, prediction of outcome, and Axis II comorbidity. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 1998 Apr:43(3):265-70     [PubMed PMID: 9561315]


[65]

Zimmerman M, Mattia JI. Axis I diagnostic comorbidity and borderline personality disorder. Comprehensive psychiatry. 1999 Jul-Aug:40(4):245-52     [PubMed PMID: 10428182]


[66]

Black DW, Blum N, Pfohl B, Hale N. Suicidal behavior in borderline personality disorder: prevalence, risk factors, prediction, and prevention. Journal of personality disorders. 2004 Jun:18(3):226-39     [PubMed PMID: 15237043]


[67]

Tate AE, Sahlin H, Liu S, Lu Y, Lundström S, Larsson H, Lichtenstein P, Kuja-Halkola R. Borderline personality disorder: associations with psychiatric disorders, somatic illnesses, trauma, and adverse behaviors. Molecular psychiatry. 2022 May:27(5):2514-2521. doi: 10.1038/s41380-022-01503-z. Epub 2022 Mar 18     [PubMed PMID: 35304564]


[68]

Parmar A, Kaloiya G. Comorbidity of Personality Disorder among Substance Use Disorder Patients: A Narrative Review. Indian journal of psychological medicine. 2018 Nov-Dec:40(6):517-527. doi: 10.4103/IJPSYM.IJPSYM_164_18. Epub     [PubMed PMID: 30533947]

Level 3 (low-level) evidence

[69]

Bender DS. The therapeutic alliance in the treatment of personality disorders. Journal of psychiatric practice. 2005 Mar:11(2):73-87     [PubMed PMID: 15803042]